FDA Inspection 1208493 — Wello, Inc.

Wello, Inc. — FEI 3011214569

The FDA completed an inspection of Wello, Inc. on June 21, 2023 in Addison, TX. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 21, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Addison, TX (United States)

Citations

IDCFRDescription
312121 CFR 820.80(b)Lack of or inadequate receiving acceptance procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
340921 CFR 820.200(d)Service reports
342621 CFR 820.50(a)(1)Documented evaluation
367621 CFR 820.30(f)Design verification - documentation
368621 CFR 820.90(b)(2)Product rework documentation, DHR {see also 820.184}
369621 CFR 820.100(b)Documentation